A Phase 1, Randomised, Open-label, 2-cohort, Cross-over Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Native Oral Testosterone Formulation (DITEST) in the Fed and Fasted State and Compared to Testosterone Undecanoate in Adult Men With Primary or Secondary Hypogonadism
Latest Information Update: 25 Mar 2022
At a glance
- Drugs Testosterone (Primary) ; Testosterone undecanoate
- Indications Hypogonadism
- Focus First in man; Pharmacokinetics; Proof of concept
- Sponsors Diurnal
Most Recent Events
- 24 Feb 2020 New trial record